[Ip-health] The 2016 Tufts estimates of the risk adjusted out-of-pocket costs to develop a new drug. | Knowledge Ecology International

Michael H Davis m.davis at csuohio.edu
Wed Apr 13 05:04:21 PDT 2016


I don't know about Joe but most of us would ask to see the original data before reaching any conclusions. Otherwise it's just self serving statements that barely justify the circular file at best.



Sent from my T-Mobile 4G LTE Device


-------- Original message --------
From: Jamie Love <james.love at keionline.org>
Date: 13/04/2016 02:27 (GMT-05:00)
To: Ip-health <ip-health at lists.keionline.org>, Joseph DiMasi <joseph.dimasi at tufts.edu>
Subject: [Ip-health] The 2016 Tufts estimates of the risk adjusted out-of-pocket costs to develop a new drug. | Knowledge Ecology International

http://keionline.org/node/2464

​I wrote a note which explains some of the issues in the way that the 2016
Tufts/DiMasi report estimates the out-of-pocket and risk adjusted costs of
drug development.

Joe can point out anything he things is wrong here, and I'll fix it if
necessary.

Jamie
_______________________________________________
Ip-health mailing list
Ip-health at lists.keionline.org
http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org


More information about the Ip-health mailing list